BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Laser capture microdissection
,
Fenofibrate
,
rs2476601
,
PDX1
,
Hepatitis
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cdc20
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Fetal liver
Thymus gland
Bone marrow
Hematopoietic stem cell of bone marrow
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Female infertility
Sepsis due to Gram negative bacteria
Epstein-Barr virus disease
Injury of liver
Liver regeneration
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
5-(6)-carboxyfluorescein diacetate succinimidyl ester
HIV Protease Inhibitors
Faslodex
aroclor 1260
Reverse Transcriptase Inhibitors
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR103A2
ECD
PFKL
DUSP5
DBI
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Bioinformatics analysis and experimental validation reveal that CDC20 overexpression promotes bladde…
Functional analysis of recurrent CDC20 promoter variants in human melanoma.
Targeting Cdc20 for cancer therapy.
CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression.
Current Progress and Perspectives of CDC20 in Female Reproductive Cancers.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer …
Elacestrant in Preoperative Setting, a Window of Opportunity Study
PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomar…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ